Tetrastarch in cardiac surgery: Error, confounding and bias in a meta-analysis of randomized trials

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Navickis, Roberta J ^a   Haynes, Gary R ^b   Wilkes, Mahlon M ^a  

^a Department of Anesthesia Services Cabell Huntington Hospital ^*  (United States)

^b Cabell Huntington Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HETASTARCH; STARCH; TETRASTARCH; UNCLASSIFIED DRUG; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

FOOD AND DRUG ADMINISTRATION; HEART SURGERY; HUMAN; LETTER; META ANALYSIS (TOPIC); OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; SYSTEMATIC ERROR; ADVERSE EFFECTS; BLOOD LOSS, SURGICAL;

BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; PLASMA SUBSTITUTES;

EID: 84928169553     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0907-8     Document Type: Letter

References (8)

1. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144:223-30.
2. Food and Drug Administration. FDA Safety Communication: boxed warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings (2013). www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm358271.htm . Accessed 5 Feb 2015.
3. Jacob M, Fellahi JL, Chappell D, Kurz A. The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis. Crit Care. 2014;18:656.
4. Kamra C, Beney A. Human albumin in extracorporeal prime: effect on platelet function and bleeding. Perfusion. 2013;28:536-40.
5. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg. 2008;107:382-90.
6. Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg. 2008;97:259-65.
7. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010;76:584-91.
8. Hanart C, Khalife M, De Villé A, Otte F, De Hert S, van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med. 2009;37:696-701.